The global C-reactive protein testing market size is expected to reach USD 5.67 billion by 2030 and is projected to grow at a CAGR of 0.26% from 2023 to 2030. The growth of C-reactive protein (CRP) testing can be attributed to significant research activities aimed at exploring various applications of testing. These research efforts are further facilitated by the presence of both private and public agencies that provide funding to expedite research in this field. The market is anticipated to witness significant growth owing to advancements in nanotechnological tools. These advancements offer promising opportunities to develop portable bioanalytical assays that possess attributes, such as high specificity, sensitivity, rapid response time, and the ability to perform multiplexing for accurate disease diagnosis and monitoring at the point of care. ![Global C-reactive Protein Testing Market]( "Global C-reactive Protein Testing Market")
These advancements are expected to drive the demand for CRP testing during the forecast period. Furthermore, an increase in strategic deals and developments, as well as higher investments in research and development has fueled the growth. The COVID-19 pandemic has had a considerable impact on the market, as CRP is considered a crucial biomarker for assessing the severity of infection and inflammation. As a result, there is an increased demand for services and products. Leading companies, such as Abbott, provide supportive tools for CRP testing specifically for SARS-CoV-2 infection, further contributing to market growth. Moreover, key players increased focus on product launches and developments in point-of-care CRP tests, which is projected to further fuel the market's growth in the coming years.
For instance, in July 2022, Bloom Diagnostics introduced the Bloom Inflammation Test, a semi-automated testing kit designed for the quantification of CRP levels in the blood. This single-use kit aids in the detection of inflammation within the body. The growth of the marketplace is expected to be further stimulated by the establishment of testing facilities. In June 2021, Trivitron Healthcare unveiled a mobile laboratory for COVID-19 diagnostics, enabling testing services in various regions of India, including rural, urban, and remote areas. This indigenous laboratory offers a range of tests, including CLIA/Elisa tests for inflammatory markers, such as a CRP, IL-6, and D-Dimer, as well as rapid antigen tests, RT-PCR tests, CLIA/Elisa Antibodies Tests IgM and IgG, and others.
North America held the largest revenue share of 39.42% in 2022 and is expected to maintain its share during the forecast period due to the increasing prevalence of cardiovascular diseases, a steady stream of product launches, presence of established market players, technological advancements, and well-developed healthcare infrastructure. Asia Pacific is projected to grow at the fastest CAGR of 0.49% from 2023 to 2030. The COVID-19 pandemic originated in China. Being the potential biomarker for determining the severity of the infection, the demand for CRP testing is expected to increase shortly. Key players operating in the global industry are constantly focusing on product launches and geographical expansion to maintain their presence.
These advancements are expected to drive the demand for CRP testing during the forecast period. Furthermore, an increase in strategic deals and developments, as well as higher investments in research and development has fueled the growth. The COVID-19 pandemic has had a considerable impact on the market, as CRP is considered a crucial biomarker for assessing the severity of infection and inflammation. As a result, there is an increased demand for services and products. Leading companies, such as Abbott, provide supportive tools for CRP testing specifically for SARS-CoV-2 infection, further contributing to market growth. Moreover, key players increased focus on product launches and developments in point-of-care CRP tests, which is projected to further fuel the market's growth in the coming years.
For instance, in July 2022, Bloom Diagnostics introduced the Bloom Inflammation Test, a semi-automated testing kit designed for the quantification of CRP levels in the blood. This single-use kit aids in the detection of inflammation within the body. The growth of the marketplace is expected to be further stimulated by the establishment of testing facilities. In June 2021, Trivitron Healthcare unveiled a mobile laboratory for COVID-19 diagnostics, enabling testing services in various regions of India, including rural, urban, and remote areas. This indigenous laboratory offers a range of tests, including CLIA/Elisa tests for inflammatory markers, such as a CRP, IL-6, and D-Dimer, as well as rapid antigen tests, RT-PCR tests, CLIA/Elisa Antibodies Tests IgM and IgG, and others.
North America held the largest revenue share of 39.42% in 2022 and is expected to maintain its share during the forecast period due to the increasing prevalence of cardiovascular diseases, a steady stream of product launches, presence of established market players, technological advancements, and well-developed healthcare infrastructure. Asia Pacific is projected to grow at the fastest CAGR of 0.49% from 2023 to 2030. The COVID-19 pandemic originated in China. Being the potential biomarker for determining the severity of the infection, the demand for CRP testing is expected to increase shortly. Key players operating in the global industry are constantly focusing on product launches and geographical expansion to maintain their presence.
C-reactive Protein Testing Market Report Highlights
- Based on assay type, the immunoturbidimetric assay segment held the largest revenue share of 48.53% in 2022. Owing to the introduction of a highly sensitive, automated, and cost-effective immunoturbidimetric assay that offers a wide measuring range for accurately detecting the levels of CRP in samples
- Based on detection ranges, the hs-CRP segment dominated the market in 2022 with a revenue share of approximately 42.80%. The hs-CRP features a broad detection range than that compared to the conventional CRP
- Based on disease area type, the cardiovascular diseases segment dominated the market with the largest market share in 2022 and is anticipated to dominate the market throughout the forecast period. The increase in the prevalence of CVDs is the major factor contributing to the growth of the CRP testing market
- The hospitals end-user segment dominated with a market share of 28.01% in 2022 due to the increased adoption of CRP testing in hospitals, particularly in response to the COVID-19 pandemic. This has led to a higher testing rate and contributed to the segment's growth
- Furthermore, the marketplace is experiencing growth due to the increasing prevalence of chronic heart diseases and cancers. These conditions contribute significantly to the market's expansion as there is a rising demand for CRP testing in the diagnosis, management, and monitoring of these diseases
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective - 1
1.9.2. Objective - 2
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective - 1
1.9.2. Objective - 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing R&D in the field of C-reactive protein testing
3.2.1.2. Rising incidence of chronic disorders
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of alternative disease testing methods
3.2.3. Market Opportunity Analysis
3.2.3.1. Technological advancements pertaining to conventional CRP tests
3.2.3.2. Growing adoption of point-of-care tests
3.2.4. Market Threat Analysis
3.2.4.1. Threat analysis on conventional CRP tests
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing R&D in the field of C-reactive protein testing
3.2.1.2. Rising incidence of chronic disorders
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of alternative disease testing methods
3.2.3. Market Opportunity Analysis
3.2.3.1. Technological advancements pertaining to conventional CRP tests
3.2.3.2. Growing adoption of point-of-care tests
3.2.4. Market Threat Analysis
3.2.4.1. Threat analysis on conventional CRP tests
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Assay Type Business Analysis
4.1. C-reactive Protein (CRP) Testing Market: Assay Type Movement Analysis
4.2. Immunoturbidimetric Assay
4.2.1. Immunoturbidimetric Assay Market, 2018 - 2030 (USD Million)
4.3. ELISA
4.3.1. ELISA Market, 2018 - 2030 (USD Million)
4.3.2. Clinical ELISA
4.3.2.1. Clinical ELISA Market, 2018 - 2030 (USD Million)
4.3.3. Nonclinical ELISA
4.3.3.1. Nonclinical ELISA Market, 2018 - 2030 (USD Million)
4.4. Chemiluminescence Immunoassay
4.4.1. Chemiluminescence Immunoassay Market, 2018 - 2030 (USD Million)
4.5. Others
4.5.1. Others Market, 2018 - 2030 (USD Million)
4.2. Immunoturbidimetric Assay
4.2.1. Immunoturbidimetric Assay Market, 2018 - 2030 (USD Million)
4.3. ELISA
4.3.1. ELISA Market, 2018 - 2030 (USD Million)
4.3.2. Clinical ELISA
4.3.2.1. Clinical ELISA Market, 2018 - 2030 (USD Million)
4.3.3. Nonclinical ELISA
4.3.3.1. Nonclinical ELISA Market, 2018 - 2030 (USD Million)
4.4. Chemiluminescence Immunoassay
4.4.1. Chemiluminescence Immunoassay Market, 2018 - 2030 (USD Million)
4.5. Others
4.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Detection Range Business Analysis
5.1. C-reactive Protein (CRP) Testing Market: Detection Range Movement Analysis
5.2. High Sensitivity C-reactive Protein (hs-CRP)
5.2.1. High Sensitivity C-reactive Protein (hs-CRP) Market, 2018 - 2030 (USD Million)
5.3. Conventional CRP
5.3.1. Conventional CRP Market, 2018 - 2030 (USD Million)
5.4. Cardiac CRP (cCRP)
5.4.1. Cardiac CRP (CCRP) Market, 2018 - 2030 (USD Million)
5.2. High Sensitivity C-reactive Protein (hs-CRP)
5.2.1. High Sensitivity C-reactive Protein (hs-CRP) Market, 2018 - 2030 (USD Million)
5.3. Conventional CRP
5.3.1. Conventional CRP Market, 2018 - 2030 (USD Million)
5.4. Cardiac CRP (cCRP)
5.4.1. Cardiac CRP (CCRP) Market, 2018 - 2030 (USD Million)
Chapter 6. Disease Area Business Analysis
6.1. C-reactive Protein (CRP) Testing Market: Disease Area Movement Analysis
6.2. Cardiovascular Diseases
6.2.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
6.3. Cancer
6.3.1. Cancer Market, 2018 - 2030 (USD Million)
6.4. Rheumatoid Arthritis
6.4.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
6.5. Inflammatory Bowel Disease
6.5.1. Inflammatory Bowel Disease Market, 2018 - 2030 (USD Million)
6.6. Endometriosis
6.6.1. Endometriosis Market, 2018 - 2030 (USD Million)
6.7. Lupus
6.7.1. Lupus Market, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Others Market, 2018 - 2030 (USD Million)
6.2. Cardiovascular Diseases
6.2.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
6.3. Cancer
6.3.1. Cancer Market, 2018 - 2030 (USD Million)
6.4. Rheumatoid Arthritis
6.4.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
6.5. Inflammatory Bowel Disease
6.5.1. Inflammatory Bowel Disease Market, 2018 - 2030 (USD Million)
6.6. Endometriosis
6.6.1. Endometriosis Market, 2018 - 2030 (USD Million)
6.7. Lupus
6.7.1. Lupus Market, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. End-use Business Analysis
7.1. C-reactive Protein (CRP) Testing Market: End-use Movement Analysis
7.2. Clinics
7.2.1. Clinics Market, 2018 - 2030 (USD Million)
7.2.2. Clinics, by entity
7.2.2.1. Physician offices
7.2.2.1.1. Physician Offices Market, 2018 - 2030 (USD Million)
7.2.2.2. Small clinics
7.2.2.2.1. Small Clinics Market, 2018 - 2030 (USD Million)
7.2.2.3. Others
7.2.2.3.1. Others Market, 2018 - 2030 (USD Million)
7.2.3. Clinics, by setting
7.2.3.1. Urban setting
7.2.3.1.1. Urban Setting Market, 2018 - 2030 (USD Million)
7.2.3.2. Rural settings
7.2.3.2.1. Rural Settings Market, 2018 - 2030 (USD Million)
7.3. Hospitals
7.3.1. Hospitals Market, 2018 - 2030 (USD Million)
7.3.2. Urban setting
7.3.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
7.3.3. Rural settings
7.3.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
7.4. Laboratories
7.4.1. Laboratories Market, 2018 - 2030 (USD Million)
7.4.2. Urban setting
7.4.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
7.4.3. Rural settings
7.4.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
7.5. Assisted Living Healthcare Facilities
7.5.1. Assisted Living Healthcare Facilities Market, 2018 - 2030 (USD Million)
7.5.2. Urban setting
7.5.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
7.5.3. Rural settings
7.5.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
7.6. Home
7.6.1. Home Market, 2018 - 2030 (USD Million)
7.7. Others
7.7.1. Others Market, 2018 - 2030 (USD Million)
7.2. Clinics
7.2.1. Clinics Market, 2018 - 2030 (USD Million)
7.2.2. Clinics, by entity
7.2.2.1. Physician offices
7.2.2.1.1. Physician Offices Market, 2018 - 2030 (USD Million)
7.2.2.2. Small clinics
7.2.2.2.1. Small Clinics Market, 2018 - 2030 (USD Million)
7.2.2.3. Others
7.2.2.3.1. Others Market, 2018 - 2030 (USD Million)
7.2.3. Clinics, by setting
7.2.3.1. Urban setting
7.2.3.1.1. Urban Setting Market, 2018 - 2030 (USD Million)
7.2.3.2. Rural settings
7.2.3.2.1. Rural Settings Market, 2018 - 2030 (USD Million)
7.3. Hospitals
7.3.1. Hospitals Market, 2018 - 2030 (USD Million)
7.3.2. Urban setting
7.3.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
7.3.3. Rural settings
7.3.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
7.4. Laboratories
7.4.1. Laboratories Market, 2018 - 2030 (USD Million)
7.4.2. Urban setting
7.4.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
7.4.3. Rural settings
7.4.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
7.5. Assisted Living Healthcare Facilities
7.5.1. Assisted Living Healthcare Facilities Market, 2018 - 2030 (USD Million)
7.5.2. Urban setting
7.5.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
7.5.3. Rural settings
7.5.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
7.6. Home
7.6.1. Home Market, 2018 - 2030 (USD Million)
7.7. Others
7.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. C-reactive Protein (CRP) Testing Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. U.S. C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Canada C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.3. North America
8.3.1. SWOT Analysis
8.3.2. North America C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.3.3. U.S.
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. U.S. C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.3.4. Canada
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Canada C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4. Europe
8.4.1. SWOT Analysis
8.4.2. Europe C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.3. UK
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. UK C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.4. Germany
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Germany C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.5. France
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. France C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.6. Italy
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Italy C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.7. Spain
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Spain C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.10. Denmark
8.4.10.1. Key Country Dynamics
8.4.10.2. Competitive Scenario
8.4.10.3. Regulatory Framework
8.4.10.4. Denmark C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5. Asia Pacific
8.5.1. SWOT Analysis
8.5.2. Asia Pacific C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.5. Japan
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Japan C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Thailand C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.7. South Korea
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. South Korea C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.8. Australia
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Australia C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.6. Latin America
8.6.1. SWOT Analysis
8.6.2. Latin America C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.6.3. Brazil
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Brazil C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.6.4. Mexico
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Mexico C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.6.5. Argentina
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Argentina C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.7. MEA
8.7.1. SWOT Analysis
8.7.2. MEA C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Saudi Arabia C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.7.4. South Africa
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. South Africa C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.7.5. UAE
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. UAE C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.7.6. Kuwait
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Kuwait C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. U.S. C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Canada C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.3. North America
8.3.1. SWOT Analysis
8.3.2. North America C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.3.3. U.S.
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. U.S. C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.3.4. Canada
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Canada C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4. Europe
8.4.1. SWOT Analysis
8.4.2. Europe C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.3. UK
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. UK C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.4. Germany
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Germany C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.5. France
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. France C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.6. Italy
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Italy C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.7. Spain
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Spain C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.4.10. Denmark
8.4.10.1. Key Country Dynamics
8.4.10.2. Competitive Scenario
8.4.10.3. Regulatory Framework
8.4.10.4. Denmark C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5. Asia Pacific
8.5.1. SWOT Analysis
8.5.2. Asia Pacific C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.5. Japan
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Japan C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Thailand C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.7. South Korea
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. South Korea C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.5.8. Australia
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Australia C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.6. Latin America
8.6.1. SWOT Analysis
8.6.2. Latin America C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.6.3. Brazil
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Brazil C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.6.4. Mexico
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Mexico C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.6.5. Argentina
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Argentina C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.7. MEA
8.7.1. SWOT Analysis
8.7.2. MEA C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Saudi Arabia C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.7.4. South Africa
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. South Africa C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.7.5. UAE
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. UAE C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
8.7.6. Kuwait
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Kuwait C-reactive Protein (CRP) Testing Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. F. Hoffmann-La Roche Ltd
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Danaher
9.4.2.1. Overview
9.4.2.1.1. Beckman Coulter, Inc.
9.4.2.1.2. Radiometer
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Thermo Fisher Scientific Inc.
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Quest Diagnostics Incorporated
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Siemens
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Abbott Laboratories
9.4.6.1. Overview
9.4.6.1.1. Alere Inc.
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Laboratory Corporation of America Holdings (LabCorp)
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Merck KGaA
9.4.8.1. Overview
9.4.8.1.1. Sigma-Aldrich Co. LLC.
9.4.8.1.2. Merck Millipore
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Abaxis, Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Ortho Clinical Diagnostics
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Getein Biotech, Inc.
9.4.11.1. Overview
9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.11.3. Product Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. HORIBA, Ltd.
9.4.12.1. Overview
9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.12.3. Product Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. RandoxLaboratories Ltd.
9.4.13.1. Overview
9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.13.3. Product Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. BODITECH MED, INC
9.4.14.1. Overview
9.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.14.3. Product Benchmarking
9.4.14.4. Strategic Initiatives
9.4.15. Aidian
9.4.15.1. Overview
9.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.15.3. Product Benchmarking
9.4.15.4. Strategic Initiatives
9.4.16. EurolyserDiagnostica GmbH
9.4.16.1. Overview
9.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.16.3. Product Benchmarking
9.4.16.4. Strategic Initiatives
9.4.17. Abcam plc
9.4.17.1. Overview
9.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.17.3. Product Benchmarking
9.4.17.4. Strategic Initiatives
9.4.18. Bio-Techne
9.4.18.1. Overview
9.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.18.3. Product Benchmarking
9.4.18.4. Strategic Initiatives
9.4.19. EKF Diagnostics
9.4.19.1. Overview
9.4.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.19.3. Product Benchmarking
9.4.19.4. Strategic Initiatives
9.4.20. SD Biosensor, INC.
9.4.20.1. Overview
9.4.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.20.3. Product Benchmarking
9.4.20.4. Strategic Initiatives
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. F. Hoffmann-La Roche Ltd
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Danaher
9.4.2.1. Overview
9.4.2.1.1. Beckman Coulter, Inc.
9.4.2.1.2. Radiometer
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Thermo Fisher Scientific Inc.
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Quest Diagnostics Incorporated
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Siemens
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Abbott Laboratories
9.4.6.1. Overview
9.4.6.1.1. Alere Inc.
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Laboratory Corporation of America Holdings (LabCorp)
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Merck KGaA
9.4.8.1. Overview
9.4.8.1.1. Sigma-Aldrich Co. LLC.
9.4.8.1.2. Merck Millipore
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Abaxis, Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Ortho Clinical Diagnostics
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Getein Biotech, Inc.
9.4.11.1. Overview
9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.11.3. Product Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. HORIBA, Ltd.
9.4.12.1. Overview
9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.12.3. Product Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. RandoxLaboratories Ltd.
9.4.13.1. Overview
9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.13.3. Product Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. BODITECH MED, INC
9.4.14.1. Overview
9.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.14.3. Product Benchmarking
9.4.14.4. Strategic Initiatives
9.4.15. Aidian
9.4.15.1. Overview
9.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.15.3. Product Benchmarking
9.4.15.4. Strategic Initiatives
9.4.16. EurolyserDiagnostica GmbH
9.4.16.1. Overview
9.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.16.3. Product Benchmarking
9.4.16.4. Strategic Initiatives
9.4.17. Abcam plc
9.4.17.1. Overview
9.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.17.3. Product Benchmarking
9.4.17.4. Strategic Initiatives
9.4.18. Bio-Techne
9.4.18.1. Overview
9.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.18.3. Product Benchmarking
9.4.18.4. Strategic Initiatives
9.4.19. EKF Diagnostics
9.4.19.1. Overview
9.4.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.19.3. Product Benchmarking
9.4.19.4. Strategic Initiatives
9.4.20. SD Biosensor, INC.
9.4.20.1. Overview
9.4.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.20.3. Product Benchmarking
9.4.20.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 4 Global C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 5 Global C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 6 Global C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 7 Global C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 8 Global C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 9 Global C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 10 Global C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 11 Global C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 12 Global C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 13 North America C-Reactive Protein (CRP) Testing Market, By Country, 2018 - 2030 (USD Million)
Table 14 North America C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 15 North America C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 16 North America C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 17 North America C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 18 North America C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 19 North America C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 20 North America C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 21 North America C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 22 North America C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 23 North America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 24 U.S. C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 25 U.S. C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 26 U.S. C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 27 U.S. C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 28 U.S. C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 29 U.S. C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 30 U.S. C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 31 U.S. C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 32 U.S. C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 33 U.S. C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 34 Canada C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 35 Canada C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 36 Canada C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 37 Canada C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 38 Canada C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 39 Canada C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 40 Canada C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 41 Canada C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 42 Canada C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 43 Canada C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 44 Europe C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 45 Europe C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 46 Europe C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 47 Europe C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 48 Europe C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 49 Europe C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 50 Europe C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 51 Europe C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 52 Europe C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 53 Europe C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 54 Germany C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 55 Germany C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 56 Germany C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 57 Germany C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 58 Germany C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 59 Germany C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 60 Germany C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 61 Germany C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 62 Germany C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 63 Germany C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 64 UK C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 65 UK C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 66 UK C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 67 UK C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 68 UK C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 69 UK C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 70 UK C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 71 UK C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 72 UK C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 73 UK C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 74 France C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 75 France C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 76 France C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 77 France C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 78 France C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 79 France C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 80 France C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 81 France C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 82 France C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 83 France C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 84 Italy C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 85 Italy C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 86 Italy C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 87 Italy C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 88 Italy C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 89 Italy C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 90 Italy C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 91 Italy C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 92 Italy C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 93 Italy C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 94 Spain C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 95 Spain C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 96 Spain C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 97 Spain C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 98 Spain C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 99 Spain C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 100 Spain C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 101 Spain C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 102 Spain C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 103 Spain C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 104 Sweden C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 105 Sweden C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 106 Sweden C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 107 Sweden C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 108 Sweden C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 109 Sweden C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 110 Sweden C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 111 Sweden C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 112 Sweden C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 113 Sweden C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 114 Denmark C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 115 Denmark C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 116 Denmark C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 117 Denmark C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 118 Denmark C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 119 Denmark C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 120 Denmark C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 121 Denmark C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 122 Denmark C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 123 Denmark C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 124 Norway C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 125 Norway C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 126 Norway C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 127 Norway C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 128 Norway C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 129 Norway C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 130 Norway C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 131 Norway C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 132 Norway C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 133 Norway C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 134 Asia Pacific C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 135 Asia Pacific C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 136 Asia Pacific C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 137 Asia Pacific C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 138 Asia Pacific C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 139 Asia Pacific C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 140 Asia Pacific C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 141 Asia Pacific C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 142 Asia Pacific C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 143 Asia Pacific C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 144 Japan C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 145 Japan C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 146 Japan C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 147 Japan C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 148 Japan C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 149 Japan C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 150 Japan C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 151 Japan C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 152 Japan C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 153 Japan C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 154 China C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 155 China C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 156 China C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 157 China C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 158 China C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 159 China C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 160 China C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 161 China C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 162 China C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 163 China C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 164 India C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 165 India C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 166 India C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 167 India C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 168 India C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 169 India C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 170 India C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 171 India C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 172 India C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 173 India C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 174 Australia C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 175 Australia C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 176 Australia C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 177 Australia C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 178 Australia C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 179 Australia C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 180 Australia C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 181 Australia C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 182 Australia C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 183 Australia C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 184 South Korea C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 185 South Korea C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 186 South Korea C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 187 South Korea C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 188 South Korea C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 189 South Korea C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 190 South Korea C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 191 South Korea C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 192 South Korea C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 193 South Korea C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 194 Thailand C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 195 Thailand C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 196 Thailand C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 197 Thailand C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 198 Thailand C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 199 Thailand C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 200 Thailand C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 201 Thailand C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 202 Thailand C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 203 Thailand C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 204 Latin America C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 205 U.S. C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 206 Latin America C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 207 Latin America C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 208 U.S. C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 209 Latin America C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 210 Latin America C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 211 Latin America C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 212 Latin America C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 213 Latin America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 214 Brazil C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 215 Brazil C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 216 Brazil C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 217 Brazil C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 218 Brazil C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 219 Brazil C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 220 Brazil C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 221 Brazil C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 222 Brazil C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 223 Brazil C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 224 Mexico C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 225 Mexico C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 226 Mexico C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 227 Mexico C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 228 Mexico C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 229 Mexico C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 230 Mexico C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 231 Mexico C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 232 Mexico C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 233 Mexico C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 234 Argentina C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 235 Argentina C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 236 Argentina C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 237 Argentina C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 238 Argentina C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 239 Argentina C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 240 Argentina C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 241 Argentina C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 242 Argentina C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 243 Argentina C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 244 MEA C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 245 MEA C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 246 MEA C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 247 MEA C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 248 MEA C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 249 MEA C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 250 MEA C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 251 MEA C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 252 MEA C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 253 MEA C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 254 South Africa C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 255 South Africa C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 256 South Africa C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 257 South Africa C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 258 South Africa C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 259 South Africa C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 260 South Africa C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 261 South Africa C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 262 South Africa C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 263 South Africa C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 264 Saudi Arabia C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 265 Saudi Arabia C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 266 Saudi Arabia C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 267 Saudi Arabia C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 268 Saudi Arabia C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 269 Saudi Arabia C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 270 Saudi Arabia C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 271 Saudi Arabia C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 272 Saudi Arabia C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 273 Saudi Arabia C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 274 UAE C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 275 UAE C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 276 UAE C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 277 UAE C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 278 UAE C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 279 UAE C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 280 UAE C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 281 UAE C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 282 UAE C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 283 UAE C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 284 Kuwait C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 285 Kuwait C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 286 Kuwait C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 287 Kuwait C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 288 Kuwait C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 289 Kuwait C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 290 Kuwait C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 291 Kuwait C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 292 Kuwait C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 293 Kuwait C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 294 List of key emerging companies
Table 2 List of Abbreviation
Table 3 Global C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 4 Global C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 5 Global C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 6 Global C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 7 Global C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 8 Global C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 9 Global C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 10 Global C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 11 Global C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 12 Global C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 13 North America C-Reactive Protein (CRP) Testing Market, By Country, 2018 - 2030 (USD Million)
Table 14 North America C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 15 North America C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 16 North America C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 17 North America C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 18 North America C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 19 North America C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 20 North America C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 21 North America C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 22 North America C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 23 North America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 24 U.S. C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 25 U.S. C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 26 U.S. C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 27 U.S. C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 28 U.S. C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 29 U.S. C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 30 U.S. C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 31 U.S. C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 32 U.S. C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 33 U.S. C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 34 Canada C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 35 Canada C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 36 Canada C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 37 Canada C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 38 Canada C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 39 Canada C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 40 Canada C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 41 Canada C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 42 Canada C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 43 Canada C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 44 Europe C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 45 Europe C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 46 Europe C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 47 Europe C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 48 Europe C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 49 Europe C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 50 Europe C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 51 Europe C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 52 Europe C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 53 Europe C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 54 Germany C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 55 Germany C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 56 Germany C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 57 Germany C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 58 Germany C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 59 Germany C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 60 Germany C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 61 Germany C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 62 Germany C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 63 Germany C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 64 UK C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 65 UK C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 66 UK C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 67 UK C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 68 UK C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 69 UK C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 70 UK C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 71 UK C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 72 UK C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 73 UK C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 74 France C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 75 France C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 76 France C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 77 France C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 78 France C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 79 France C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 80 France C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 81 France C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 82 France C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 83 France C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 84 Italy C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 85 Italy C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 86 Italy C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 87 Italy C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 88 Italy C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 89 Italy C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 90 Italy C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 91 Italy C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 92 Italy C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 93 Italy C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 94 Spain C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 95 Spain C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 96 Spain C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 97 Spain C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 98 Spain C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 99 Spain C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 100 Spain C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 101 Spain C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 102 Spain C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 103 Spain C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 104 Sweden C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 105 Sweden C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 106 Sweden C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 107 Sweden C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 108 Sweden C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 109 Sweden C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 110 Sweden C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 111 Sweden C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 112 Sweden C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 113 Sweden C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 114 Denmark C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 115 Denmark C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 116 Denmark C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 117 Denmark C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 118 Denmark C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 119 Denmark C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 120 Denmark C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 121 Denmark C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 122 Denmark C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 123 Denmark C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 124 Norway C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 125 Norway C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 126 Norway C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 127 Norway C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 128 Norway C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 129 Norway C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 130 Norway C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 131 Norway C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 132 Norway C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 133 Norway C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 134 Asia Pacific C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 135 Asia Pacific C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 136 Asia Pacific C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 137 Asia Pacific C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 138 Asia Pacific C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 139 Asia Pacific C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 140 Asia Pacific C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 141 Asia Pacific C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 142 Asia Pacific C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 143 Asia Pacific C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 144 Japan C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 145 Japan C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 146 Japan C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 147 Japan C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 148 Japan C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 149 Japan C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 150 Japan C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 151 Japan C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 152 Japan C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 153 Japan C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 154 China C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 155 China C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 156 China C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 157 China C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 158 China C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 159 China C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 160 China C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 161 China C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 162 China C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 163 China C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 164 India C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 165 India C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 166 India C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 167 India C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 168 India C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 169 India C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 170 India C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 171 India C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 172 India C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 173 India C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 174 Australia C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 175 Australia C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 176 Australia C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 177 Australia C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 178 Australia C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 179 Australia C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 180 Australia C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 181 Australia C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 182 Australia C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 183 Australia C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 184 South Korea C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 185 South Korea C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 186 South Korea C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 187 South Korea C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 188 South Korea C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 189 South Korea C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 190 South Korea C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 191 South Korea C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 192 South Korea C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 193 South Korea C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 194 Thailand C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 195 Thailand C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 196 Thailand C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 197 Thailand C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 198 Thailand C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 199 Thailand C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 200 Thailand C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 201 Thailand C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 202 Thailand C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 203 Thailand C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 204 Latin America C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 205 U.S. C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 206 Latin America C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 207 Latin America C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 208 U.S. C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 209 Latin America C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 210 Latin America C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 211 Latin America C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 212 Latin America C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 213 Latin America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 214 Brazil C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 215 Brazil C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 216 Brazil C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 217 Brazil C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 218 Brazil C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 219 Brazil C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 220 Brazil C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 221 Brazil C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 222 Brazil C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 223 Brazil C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 224 Mexico C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 225 Mexico C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 226 Mexico C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 227 Mexico C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 228 Mexico C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 229 Mexico C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 230 Mexico C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 231 Mexico C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 232 Mexico C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 233 Mexico C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 234 Argentina C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 235 Argentina C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 236 Argentina C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 237 Argentina C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 238 Argentina C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 239 Argentina C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 240 Argentina C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 241 Argentina C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 242 Argentina C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 243 Argentina C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 244 MEA C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 245 MEA C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 246 MEA C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 247 MEA C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 248 MEA C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 249 MEA C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 250 MEA C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 251 MEA C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 252 MEA C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 253 MEA C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 254 South Africa C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 255 South Africa C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 256 South Africa C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 257 South Africa C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 258 South Africa C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 259 South Africa C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 260 South Africa C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 261 South Africa C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 262 South Africa C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 263 South Africa C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 264 Saudi Arabia C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 265 Saudi Arabia C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 266 Saudi Arabia C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 267 Saudi Arabia C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 268 Saudi Arabia C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 269 Saudi Arabia C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 270 Saudi Arabia C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 271 Saudi Arabia C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 272 Saudi Arabia C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 273 Saudi Arabia C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 274 UAE C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 275 UAE C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 276 UAE C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 277 UAE C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 278 UAE C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 279 UAE C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 280 UAE C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 281 UAE C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 282 UAE C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 283 UAE C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 284 Kuwait C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 285 Kuwait C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 286 Kuwait C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 287 Kuwait C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 288 Kuwait C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 289 Kuwait C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 290 Kuwait C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 291 Kuwait C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 292 Kuwait C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 293 Kuwait C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 294 List of key emerging companies
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 C-reactive Protein (CRP) Testing Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Technology timeline: CRP detection
Fig. 12 Antibiotic prescribing decisions pre- and post-CRP tests in UCC study
Fig. 13 Penetration & growth prospect mapping for assay type, 2020
Fig. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 15 Porter’s Five Forces Analysis
Fig. 16 Global C-reactive protein testing market: Assay type outlook key takeaways
Fig. 17 Global C-reactive protein testing market: Assay type movement analysis
Fig. 18 Global immunoturbidimetric assay market, 2018 - 2030 (USD Million)
Fig. 19 Global ELISA market, 2018 - 2030 (USD Million)
Fig. 20 Global clinical ELISA market, 2018 - 2030 (USD Million)
Fig. 21 Global nonclinical ELISA market, 2018 - 2030 (USD Million)
Fig. 22 Global chemiluminescence immunoassay market, 2018 - 2030 (USD Million)
Fig. 23 Global others market, 2018 - 2030 (USD Million)
Fig. 24 Global C-reactive protein testing market: Detection range estimates outlook key takeaways
Fig. 25 Global C-reactive protein testing market: Detection range movement analysis
Fig. 26 Global hsCRP market, 2018 - 2030 (USD Million)
Fig. 27 Global conventional CRP market, 2018 - 2030 (USD Million)
Fig. 28 Global cardiac CRP market, 2018 - 2030 (USD Million)
Fig. 29 Global C-reactive protein testing market: Disease area estimates outlook key takeaways
Fig. 30 Global C-reactive protein testing market: Disease Area movement analysis
Fig. 31 Global cardiovascular diseases CRP tests market, 2018 - 2030 (USD Million)
Fig. 32 Global cancer CRP tests market, 2018 - 2030 (USD Million)
Fig. 33 Global rheumatoid arthritis CRP tests market, 2018 - 2030 (USD Million)
Fig. 34 Global inflammatory bowel disease CRP tests market, 2018 - 2030 (USD Million)
Fig. 35 Global endometriosis CRP tests market, 2018 - 2030 (USD Million)
Fig. 36 Global lupus CRP tests market, 2018 - 2030 (USD Million)
Fig. 37 Global others market, 2018 - 2030 (USD Million)
Fig. 38 Global C-reactive protein testing market: End-use estimates outlook key takeaways
Fig. 39 Global C-reactive protein testing market: End-use movement analysis
Fig. 40 Global clinics market, 2018 - 2030 (USD Million)
Fig. 41 Physician office visits in the U.S., by age (Thousands)
Fig. 42 Global physician office market, 2018 - 2030 (USD Million)
Fig. 43 Global small clinic market, 2018 - 2030 (USD Million)
Fig. 44 Global other clinics market, 2018 - 2030 (USD Million)
Fig. 45 Global urban setting clinics market, 2018 - 2030 (USD Million)
Fig. 46 Global rural settings clinic market, 2018 - 2030 (USD Million)
Fig. 47 Global hospitals market, 2018 - 2030 (USD Million)
Fig. 48 Global urban setting hospitals market, 2018 - 2030 (USD Million)
Fig. 49 Global rural setting hospitals market, 2018 - 2030 (USD Million)
Fig. 50 Global laboratories market, 2018 - 2030 (USD Million)
Fig. 51 Global urban setting laboratories market, 2018 - 2030 (USD Million)
Fig. 52 Global rural setting laboratories market, 2018 - 2030 (USD Million)
Fig. 53 Global assisted living healthcare facilities market, 2018 - 2030 (USD Million)
Fig. 54 Regional Outlook, 2022 & 2030
Fig. 55 Regional Market Dashboard
Fig. 56 Regional Market Place: Key Takeaways
Fig. 57 North America, SWOT Analysis
Fig. 58 Europe, SWOT Analysis
Fig. 59 Asia Pacific, SWOT Analysis
Fig. 60 Latin America, SWOT Analysis
Fig. 61 MEA, SWOT Analysis
Fig. 62 North America
Fig. 63 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 64 U.S.
Fig. 65 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 66 Canada
Fig. 67 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 68 Europe
Fig. 69 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 70 UK
Fig. 71 UK Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 72 Germany
Fig. 73 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 74 Italy
Fig. 75 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 76 France
Fig. 77 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 78 Spain
Fig. 79 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 80 Sweden
Fig. 81 Sweden Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 82 Norway
Fig. 83 Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 84 Denmark
Fig. 85 Denmark Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 86 Asia Pacific
Fig. 87 Asia-Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 88 China
Fig. 89 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 90 India
Fig. 91 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 92 Japan
Fig. 93 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 94 Australia
Fig. 95 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 96 Thailand
Fig. 97 Thailand Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 98 South Korea
Fig. 99 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 100 Latin America
Fig. 101 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 102 Brazil
Fig. 103 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 104 Mexico
Fig. 105 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 106 Argentina
Fig. 107 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 108 MEA
Fig. 109 MEA Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 110 UAE
Fig. 111 UAE Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 112 South Africa
Fig. 113 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 114 Saudi Arabia
Fig. 115 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 116 Kuwait
Fig. 117 Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 118 Strategy Mapping
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 C-reactive Protein (CRP) Testing Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Technology timeline: CRP detection
Fig. 12 Antibiotic prescribing decisions pre- and post-CRP tests in UCC study
Fig. 13 Penetration & growth prospect mapping for assay type, 2020
Fig. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 15 Porter’s Five Forces Analysis
Fig. 16 Global C-reactive protein testing market: Assay type outlook key takeaways
Fig. 17 Global C-reactive protein testing market: Assay type movement analysis
Fig. 18 Global immunoturbidimetric assay market, 2018 - 2030 (USD Million)
Fig. 19 Global ELISA market, 2018 - 2030 (USD Million)
Fig. 20 Global clinical ELISA market, 2018 - 2030 (USD Million)
Fig. 21 Global nonclinical ELISA market, 2018 - 2030 (USD Million)
Fig. 22 Global chemiluminescence immunoassay market, 2018 - 2030 (USD Million)
Fig. 23 Global others market, 2018 - 2030 (USD Million)
Fig. 24 Global C-reactive protein testing market: Detection range estimates outlook key takeaways
Fig. 25 Global C-reactive protein testing market: Detection range movement analysis
Fig. 26 Global hsCRP market, 2018 - 2030 (USD Million)
Fig. 27 Global conventional CRP market, 2018 - 2030 (USD Million)
Fig. 28 Global cardiac CRP market, 2018 - 2030 (USD Million)
Fig. 29 Global C-reactive protein testing market: Disease area estimates outlook key takeaways
Fig. 30 Global C-reactive protein testing market: Disease Area movement analysis
Fig. 31 Global cardiovascular diseases CRP tests market, 2018 - 2030 (USD Million)
Fig. 32 Global cancer CRP tests market, 2018 - 2030 (USD Million)
Fig. 33 Global rheumatoid arthritis CRP tests market, 2018 - 2030 (USD Million)
Fig. 34 Global inflammatory bowel disease CRP tests market, 2018 - 2030 (USD Million)
Fig. 35 Global endometriosis CRP tests market, 2018 - 2030 (USD Million)
Fig. 36 Global lupus CRP tests market, 2018 - 2030 (USD Million)
Fig. 37 Global others market, 2018 - 2030 (USD Million)
Fig. 38 Global C-reactive protein testing market: End-use estimates outlook key takeaways
Fig. 39 Global C-reactive protein testing market: End-use movement analysis
Fig. 40 Global clinics market, 2018 - 2030 (USD Million)
Fig. 41 Physician office visits in the U.S., by age (Thousands)
Fig. 42 Global physician office market, 2018 - 2030 (USD Million)
Fig. 43 Global small clinic market, 2018 - 2030 (USD Million)
Fig. 44 Global other clinics market, 2018 - 2030 (USD Million)
Fig. 45 Global urban setting clinics market, 2018 - 2030 (USD Million)
Fig. 46 Global rural settings clinic market, 2018 - 2030 (USD Million)
Fig. 47 Global hospitals market, 2018 - 2030 (USD Million)
Fig. 48 Global urban setting hospitals market, 2018 - 2030 (USD Million)
Fig. 49 Global rural setting hospitals market, 2018 - 2030 (USD Million)
Fig. 50 Global laboratories market, 2018 - 2030 (USD Million)
Fig. 51 Global urban setting laboratories market, 2018 - 2030 (USD Million)
Fig. 52 Global rural setting laboratories market, 2018 - 2030 (USD Million)
Fig. 53 Global assisted living healthcare facilities market, 2018 - 2030 (USD Million)
Fig. 54 Regional Outlook, 2022 & 2030
Fig. 55 Regional Market Dashboard
Fig. 56 Regional Market Place: Key Takeaways
Fig. 57 North America, SWOT Analysis
Fig. 58 Europe, SWOT Analysis
Fig. 59 Asia Pacific, SWOT Analysis
Fig. 60 Latin America, SWOT Analysis
Fig. 61 MEA, SWOT Analysis
Fig. 62 North America
Fig. 63 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 64 U.S.
Fig. 65 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 66 Canada
Fig. 67 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 68 Europe
Fig. 69 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 70 UK
Fig. 71 UK Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 72 Germany
Fig. 73 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 74 Italy
Fig. 75 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 76 France
Fig. 77 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 78 Spain
Fig. 79 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 80 Sweden
Fig. 81 Sweden Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 82 Norway
Fig. 83 Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 84 Denmark
Fig. 85 Denmark Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 86 Asia Pacific
Fig. 87 Asia-Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 88 China
Fig. 89 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 90 India
Fig. 91 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 92 Japan
Fig. 93 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 94 Australia
Fig. 95 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 96 Thailand
Fig. 97 Thailand Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 98 South Korea
Fig. 99 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 100 Latin America
Fig. 101 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 102 Brazil
Fig. 103 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 104 Mexico
Fig. 105 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 106 Argentina
Fig. 107 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 108 MEA
Fig. 109 MEA Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 110 UAE
Fig. 111 UAE Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 112 South Africa
Fig. 113 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 114 Saudi Arabia
Fig. 115 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 116 Kuwait
Fig. 117 Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 118 Strategy Mapping
Companies Mentioned
- F. Hoffmann-La Roche Ltd
- Danaher
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Siemens
- Abbott Laboratories
- Laboratory Corporation of America Holdings (LabCorp)
- Merck KGaA
- Sigma-Aldrich Co. LLC.
- Abaxis, Inc.
- Ortho Clinical Diagnostics
- Getein Biotech, Inc.
- HORIBA, Ltd.
- RandoxLaboratories Ltd.
- BODITECH MED, INC
- Aidian
- EurolyserDiagnostica GmbH
- Abcam plc
- Bio-Techne
- EKF Diagnostics
- SD Biosensor, INC.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 129 |
| Published | August 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 5.55 Billion |
| Forecasted Market Value ( USD | $ 5.67 Billion |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
